Lapatinib Completed Phase 2 Trials for Lung Tumors / Metastatic Brain Tumors / Tumors, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01218529Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors